May 15 (Reuters) - Gilead Sciences Inc GILD.O:
GILEAD AND KITE ANNOUNCE PRESENTATION OF TRANSFORMATIVE DATA IN 1L METASTATIC TRIPLE-NEGATIVE BREAST CANCER, UPDATED RESULTS IN MULTIPLE MYELOMA AND EARLY DATA FROM NOVEL INVESTIGATIONAL CAR T-CELL THERAPY TARGETING BRAIN CANCER AT 2025 ASCO AND EHA
Source text: ID:nBw8SXQW4a
Further company coverage: GILD.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.